Cytotoxic effect of the VVGMCSF-Lact oncolytic virus against 3D cultures of human glioblastoma cells U-87 MG
Background. One of the promising methods of treating tumors is virotherapy, which is based on direct lysis of cancer cells by a virus and a virus-mediated antitumor immune response of the body. For the recombinant vaccinia virus strain VVGMCSF-Lact, producing human GMCSF and the oncotoxic protein la...
Saved in:
Main Authors: | M. A. Dymova, T. A. Shnaider, S. A. Chechetkina, G. O. Petrov, D. O. Malysheva, D. V. Drokov, A. B. Ageenko, N. S. Vasileva, V. A. Richter, E. V. Kuligina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2024-01-01
|
Series: | Acta Biomedica Scientifica |
Subjects: | |
Online Access: | https://www.actabiomedica.ru/jour/article/view/4502 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01) -
Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review
by: Ayushi Garg, et al.
Published: (2025-07-01) -
Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01) -
Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01) -
A comparative study of replicative properties of antitumor recombinant vaccinia viruses on human glioblastoma cell culture U87 and monkey kidney cell culture CV-1
by: R. A. Maksyutov, et al.
Published: (2017-02-01)